SenderraRx Announces Strategic Growth Investment from Nautic Partners
SenderraRx, a premier specialty pharmacy dedicated to delivering personalized, high-touch care for patients with complex and chronic conditions, and Nautic Partners (“Nautic”) announced today that Nautic has signed a definitive agreement to make a growth investment in SenderraRx. SenderraRx's management team will remain significant investors and continue to lead the company. https://mma.prnewswire.com/media/2167372/Senderra_Specialty_Pharmacy_Logo.jpg SenderraRx, founded in […]